收费全文 | 91086篇 |
免费 | 7062篇 |
国内免费 | 1897篇 |
耳鼻咽喉 | 847篇 |
儿科学 | 1977篇 |
妇产科学 | 1147篇 |
基础医学 | 3922篇 |
口腔科学 | 4661篇 |
临床医学 | 8442篇 |
内科学 | 12057篇 |
皮肤病学 | 1596篇 |
神经病学 | 5359篇 |
特种医学 | 2647篇 |
外国民族医学 | 21篇 |
外科学 | 9597篇 |
综合类 | 15758篇 |
现状与发展 | 8篇 |
一般理论 | 4篇 |
预防医学 | 6238篇 |
眼科学 | 1545篇 |
药学 | 8670篇 |
161篇 | |
中国医学 | 9017篇 |
肿瘤学 | 6371篇 |
2024年 | 325篇 |
2023年 | 1516篇 |
2022年 | 2991篇 |
2021年 | 3981篇 |
2020年 | 3927篇 |
2019年 | 3032篇 |
2018年 | 2860篇 |
2017年 | 3155篇 |
2016年 | 3420篇 |
2015年 | 3185篇 |
2014年 | 6208篇 |
2013年 | 8454篇 |
2012年 | 5971篇 |
2011年 | 6313篇 |
2010年 | 5286篇 |
2009年 | 4630篇 |
2008年 | 4156篇 |
2007年 | 4372篇 |
2006年 | 3919篇 |
2005年 | 3354篇 |
2004年 | 2820篇 |
2003年 | 2442篇 |
2002年 | 1998篇 |
2001年 | 1657篇 |
2000年 | 1388篇 |
1999年 | 1097篇 |
1998年 | 892篇 |
1997年 | 827篇 |
1996年 | 697篇 |
1995年 | 608篇 |
1994年 | 555篇 |
1993年 | 491篇 |
1992年 | 406篇 |
1991年 | 365篇 |
1990年 | 266篇 |
1989年 | 265篇 |
1988年 | 250篇 |
1987年 | 232篇 |
1986年 | 211篇 |
1985年 | 275篇 |
1984年 | 213篇 |
1983年 | 150篇 |
1982年 | 188篇 |
1981年 | 150篇 |
1980年 | 126篇 |
1979年 | 118篇 |
1978年 | 70篇 |
1977年 | 60篇 |
1976年 | 49篇 |
1975年 | 31篇 |
Method: First, persons assessed for admittance in 2005–2011 (n?=?127) were categorized into four trajectory groups based on whether they were admitted or denied (n?=?19), discharged (n?=?31), readmitted (n?=?21) or had been undergoing OMT without interruption (n?=?56). Second, 99 of these, the analytical sample, were interviewed at follow-up using (a) the Addiction Severity Index (ASI) for seven problem-areas and housing, and (b) self-rated change in 11 problem areas. The ASI was compared to baseline interviews after 55 months (mean). Third, outcomes within groups was studied in relation to alternative interventions.
Results: Within the analytical sample, those denied OMT showed no improvements at group level, those discharged had some improvements, more if readmitted than if not and those with uninterrupted OMT showed the most comprehensive improvements. Those outside OMT, denied and discharged, had considerable mortality risks related to ongoing drug use, especially in lack of well-planned alternative interventions.
Conclusion: Improvements strongly relate to access to OMT. This study underscores that access to OMT improves the situation in all areas investigated and decreases the risk for drug-related death. It underscores the importance of two major risk situations, i.e. being denied OMT and being discharged. 相似文献
Areas covered: The many tools developed to measure disease activity in RA, from composite scores and patient-reported outcomes, to laboratory markers and imaging are discussed, with a focus on their utility in guiding therapy and assessing response. The complex issues in measuring disease activity in RA, whether in clinical trials or normal clinical practice, and in the context of national guidelines and recommendations, available time, and resources are considered.
Expert commentary: The key to effective management of RA is the rapid suppression of inflammation, ideally to remission, with maintenance of such remission. The aim is to prevent disability and maximize quality of life. Central to this is the ability to determine disease activity (potentially open to suppression) as opposed to damage (irreversible). A variety of measures are currently available, allowing better assessment of response to treatment. In the future, the development of predictive biomarkers allowing targeting of drugs may revolutionize this field and render the tools of today redundant. 相似文献
Methods: Tumour and surrounding tissue were modeled by elliptical two- and three-dimensional computational phantoms having six different nanoparticle distributions. Nanoparticles were modeled as point heat sources having amplitude-dependent loss power. The total number of nanoparticles was fixed, and their spatial distribution and heat output were varied. Heat transfer was computed by solving the Pennes’ bioheat equation using finite element methods (FEM) with temperature-dependent blood perfusion. Local temperature was regulated using a proportional-integral-derivative (PID) controller. Tissue temperature, thermal dose and tissue damage were calculated. The required minimum thermal dose delivered to the tumor was kept constant, and heating power was adjusted for comparison of both the heating methods.
Results: Modulated power heating produced lower and more homogeneous temperature distributions than did constant power heating for all studied nanoparticle distributions. For a concentrated nanoparticle distribution, located off-center within the tumor, the maximum temperatures inside the tumor were 16% lower for modulated power heating when compared to constant power heating. This resulted in less damage to surrounding normal tissue. Modulated power heating reached target thermal doses up to nine-fold more rapidly when compared to constant power heating.
Conclusions: Controlling the temperature at the tumor-healthy tissue boundary by modulating the heating power of magnetic nanoparticles demonstrably compensates for a variable nanoparticle distribution to deliver effective treatment. 相似文献